| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

(From the Kirstein Laboratory for Surgical Research, Beth Israel Hospital, Boston and the Department of Surgery, Harvard Medical School)
The preparation of a ditetrazolium salt (IV) is given. When reduced, this water-soluble, pale-yellow salt (BT) is converted to a blue, water-insoluble pigment (diformazan). The toxicity of BT in mice is greater than the toxicity of triphenyl tetrazolium chloride. Dehydrogenase activity was demonstrated mainly in liver and kidney in vivo and in vitro with BT. Results with blocks of fresh tissue differed from the results with homogenates. Specific dehydrogenase activity was demonstrated in extracts of homogenates by the addition of specific substrates such as sodium succinate, xanthine, sodium lactate, and sodium malate. Cysteine desulfurase was demonstrated with cysteine as substrate. Tumors of animals and man contained no succinic dehydrogenase and little cysteine desulfurase by this technique.
* This investigation was aided by a research grant from the National Cancer Institute, National Institutes of Health, Public Health Service, (in part) by a research grant from the American Cancer Society (Massachusetts Division) and (in part) by an institutional grant to Harvard University from the American Cancer Society.
Kirstein fellow in Surgery, Beth Israel Hospital.
This article has been cited by other articles:
![]() |
E. I. Parsons and M. Frobisher Jr. Differentiation of minimus type C. diphtheriae by slow fermentation of dextrose. Science, March 23, 1951; 113(2934): 317 - 317. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |